title: In vivo induction of regulatory T cells for immune tolerance in hemophilia.
abstract: Current therapy for the X-linked coagulation disorder hemophilia is based on intravenous infusion of the specifically deficient coagulation factor. However, 20-30% of hemophilia A patients (factor VIII, FVIII, deficiency) generate inhibitory antibodies against FVIII. While formation of inhibitors directed against factor IX, FIX, resulting from hemophilia B treatment is comparatively rare, a serious complication that is often associated with additional immunotoxicities, e.g. anaphylaxis, occurs. Current immune tolerance protocols to eradiate inhibitors are lengthy, expensive, not effective in all patients, and there are no prophylactic tolerance regimens to prevent inhibitor formation. The outcomes of recent experiments in animal models of hemophilia demonstrate that regulatory CD4(+) T cells (Treg) are of paramount importance in controlling B cell responses to FVIII and FIX. This article reviews several novel strategies designed to in vivo induce coagulation factor-specific Treg cells and discusses the subsets of Treg that may promote immune tolerance in hemophilia. Among others, drug- and gene transfer-based protocols, lymphocyte transplant, and oral tolerance are reviewed.
authors.affiliation: Dept. Pediatrics, University of Florida, Gainesville, FL 32610, USA.
authors.forename: Xiaomei
authors.initials: X
authors.lastname: Wang
authors.affiliation: Div. Immunology, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
authors.forename: Cox
authors.initials: C
authors.lastname: Terhorst
authors.affiliation: Dept. Pediatrics, University of Florida, Gainesville, FL 32610, USA. Electronic address: rherzog@ufl.edu.
authors.forename: Roland W
authors.initials: RW
authors.lastname: Herzog
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
chemical_list: D057134:Antibodies, Neutralizing; D005169:Factor VIII
keywords: FoxP3; Hemophilia; IL-10; LAP; TGF-β; Tr1; Treg